RxDoctor Payments Data

Steve Paragioudakis, MD

Orthopaedic Surgery · Shrewsbury, NJNPI 1265517999

Payments from drug & device makers

What this record shows

This record is dominated by other: $157,784 of the $163,454 with a category attached, or 96.5%. Alcon accounts for 96.5% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $158,352, more than ten times the $1,714 reported in 2019. Among orthopaedic surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$163,454in general payments, 2019–2025

Across 76 payments — averaging $2150.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$158K
  • Globus Medical$2K
  • Addivation Medical LLC$1K
  • Integrity Implants Inc. Dba Accelus$774
  • Alphatec Spine, Inc$602
  • Nevro Corp.$305
  • plus $871 from 15 others

What the payments were for

  • Consulting fees$1,0001%
  • Travel & lodging$1,5771%
  • Food & beverage$3,0932%
  • Other$157,78497%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$163,454 in reported general payments places this provider in the 90th percentile of 587 orthopaedic surgery providers in New Jersey.

See all orthopaedic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$167,526
Medicare patients
287
Services billed
1,339

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl16$104

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Shrewsbury

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →